Published in Diabetes Technol Ther on December 06, 2011
Performance evaluation of three continuous glucose monitoring systems: comparison of six sensors per subject in parallel. J Diabetes Sci Technol (2013) 1.62
Real-time improvement of continuous glucose monitoring accuracy: the smart sensor concept. Diabetes Care (2012) 1.37
Performance comparison of the medtronic sof-sensor and enlite glucose sensors in inpatient studies of individuals with type 1 diabetes. Diabetes Technol Ther (2013) 1.29
The use of an automated, portable glucose control system for overnight glucose control in adolescents and young adults with type 1 diabetes. Diabetes Care (2012) 1.27
A clinical trial of the accuracy and treatment experience of the Dexcom G4 sensor (Dexcom G4 system) and Enlite sensor (guardian REAL-time system) tested simultaneously in ambulatory patients with type 1 diabetes. Diabetes Technol Ther (2014) 1.27
Continuous glucose monitoring considerations for the development of a closed-loop artificial pancreas system. J Diabetes Sci Technol (2011) 0.95
Continuous glucose monitoring: current use and future directions. Curr Diab Rep (2013) 0.94
Large pre- and postexercise rapid-acting insulin reductions preserve glycemia and prevent early- but not late-onset hypoglycemia in patients with type 1 diabetes. Diabetes Care (2013) 0.92
Wearable and implantable pancreas substitutes. J Artif Organs (2012) 0.84
Feasibility study of a bio-inspired artificial pancreas in adults with type 1 diabetes. Diabetes Technol Ther (2014) 0.83
Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes. Diabetes Technol Ther (2017) 0.82
Assessing the Accuracy of Continuous Glucose Monitoring (CGM) Calibrated With Capillary Values Using Capillary or Venous Glucose Levels as a Reference. J Diabetes Sci Technol (2016) 0.82
Accuracy of continuous glucose monitoring during exercise in type 1 diabetes pregnancy. Diabetes Technol Ther (2013) 0.82
The Minimum Duration of Sensor Data From Which Glycemic Variability Can Be Consistently Assessed. J Diabetes Sci Technol (2014) 0.80
Insulin therapy and dietary adjustments to normalize glycemia and prevent nocturnal hypoglycemia after evening exercise in type 1 diabetes: a randomized controlled trial. BMJ Open Diabetes Res Care (2015) 0.79
The role of continuous glucose monitoring in the care of children with type 1 diabetes. Int J Pediatr Endocrinol (2013) 0.78
Evaluation of stochastic adjustment for glucose sensor bias during closed-loop insulin delivery. Diabetes Technol Ther (2013) 0.77
Signal processing algorithms implementing the "smart sensor" concept to improve continuous glucose monitoring in diabetes. J Diabetes Sci Technol (2013) 0.76
Evaluation of a minimally invasive glucose biosensor for continuous tissue monitoring. Anal Bioanal Chem (2016) 0.75
Pilot study of a prototype minimally invasive intradermal continuous glucose monitor. J Diabetes Sci Technol (2012) 0.75
Sensor Life and Overnight Closed Loop: A Randomized Clinical Trial. J Diabetes Sci Technol (2016) 0.75
Threshold-based insulin-pump interruption for reduction of hypoglycemia. N Engl J Med (2013) 6.64
Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial. Diabetes Care (2006) 5.20
Fully integrated artificial pancreas in type 1 diabetes: modular closed-loop glucose control maintains near normoglycemia. Diabetes (2012) 3.40
Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE study. Diabetes Technol Ther (2012) 2.46
Modular artificial beta-cell system: a prototype for clinical research. J Diabetes Sci Technol (2008) 2.42
Safety constraints in an artificial pancreatic beta cell: an implementation of model predictive control with insulin on board. J Diabetes Sci Technol (2009) 2.06
Accuracy of the SEVEN continuous glucose monitoring system: comparison with frequently sampled venous glucose measurements. J Diabetes Sci Technol (2009) 1.93
"Turn it off!": diabetes device alarm fatigue considerations for the present and the future. J Diabetes Sci Technol (2013) 1.77
New features and performance of a next-generation SEVEN-day continuous glucose monitoring system with short lag time. Diabetes Technol Ther (2009) 1.71
Clinical evaluation of a personalized artificial pancreas. Diabetes Care (2012) 1.69
Real-Time hypoglycemia prediction suite using continuous glucose monitoring: a safety net for the artificial pancreas. Diabetes Care (2010) 1.66
Pilot studies of wearable outpatient artificial pancreas in type 1 diabetes. Diabetes Care (2012) 1.57
Run-to-run control of blood glucose concentrations for people with Type 1 diabetes mellitus. IEEE Trans Biomed Eng (2006) 1.39
Accuracy and acceptability of the 6-day Enlite continuous subcutaneous glucose sensor. Diabetes Technol Ther (2014) 1.36
Prandial insulin dosing using run-to-run control: application of clinical data and medical expertise to define a suitable performance metric. Diabetes Care (2007) 1.36
Improved quality of glycemic control and reduced glycemic variability with use of continuous glucose monitoring. Diabetes Technol Ther (2009) 1.34
A Run-to-Run Control Strategy to Adjust Basal Insulin Infusion Rates in Type 1 Diabetes. J Process Control (2008) 1.31
In silico evaluation platform for artificial pancreatic beta-cell development--a dynamic simulator for closed-loop control with hardware-in-the-loop. Diabetes Technol Ther (2009) 1.24
Insulin pump therapy in patients with type 2 diabetes safely improved glycemic control using a simple insulin dosing regimen. Diabetes Technol Ther (2010) 1.22
Use of a novel fluorescent glucose sensor in volunteer subjects with type 1 diabetes mellitus. J Diabetes Sci Technol (2011) 1.21
Comparative glycemic control, safety and patient ratings for a new 4 mm x 32G insulin pen needle in adults with diabetes. Curr Med Res Opin (2010) 1.20
Clinical experience with an integrated continuous glucose sensor/insulin pump platform: a feasibility study. Adv Ther (2006) 1.20
In silico preclinical trials: methodology and engineering guide to closed-loop control in type 1 diabetes mellitus. J Diabetes Sci Technol (2009) 1.19
Practical issues in the identification of empirical models from simulated type 1 diabetes data. Diabetes Technol Ther (2007) 1.15
Design of the health monitoring system for the artificial pancreas: low glucose prediction module. J Diabetes Sci Technol (2012) 1.14
Closed-loop control and advisory mode evaluation of an artificial pancreatic Beta cell: use of proportional-integral-derivative equivalent model-based controllers. J Diabetes Sci Technol (2008) 1.09
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY 2016 OUTPATIENT GLUCOSE MONITORING CONSENSUS STATEMENT. Endocr Pract (2016) 1.09
Quest for the artificial pancreas: combining technology with treatment. IEEE Eng Med Biol Mag (2010) 1.09
The PILGRIM study: in silico modeling of a predictive low glucose management system and feasibility in youth with type 1 diabetes during exercise. Diabetes Technol Ther (2014) 1.08
Intensive versus modified conventional control of blood glucose level in medical intensive care patients: a pilot study. Am J Crit Care (2005) 1.08
Glucose estimation and prediction through meal responses using ambulatory subject data for advisory mode model predictive control. J Diabetes Sci Technol (2007) 1.07
An improved PID switching control strategy for type 1 diabetes. IEEE Trans Biomed Eng (2008) 1.07
OmniPod Insulin Management System: patient perceptions, preference, and glycemic control. Diabetes Care (2006) 1.06
Calculating the insulin to carbohydrate ratio using the hyperinsulinaemic-euglycaemic clamp-a novel use for a proven technique. Diabetes Metab Res Rev (2007) 1.02
Coordinated basal-bolus infusion for tighter postprandial glucose control in insulin pump therapy. J Diabetes Sci Technol (2009) 1.02
Proposed clinical application for tuning fuzzy logic controller of artificial pancreas utilizing a personalization factor. J Diabetes Sci Technol (2010) 1.00
A new test strip technology platform for self-monitoring of blood glucose. J Diabetes Sci Technol (2013) 0.98
A Feedforward-Feedback Glucose Control Strategy for Type 1 Diabetes Mellitus. J Process Control (2008) 0.95
ASPIRE In-Home: rationale, design, and methods of a study to evaluate the safety and efficacy of automatic insulin suspension for nocturnal hypoglycemia. J Diabetes Sci Technol (2013) 0.95
Continuous glucose monitoring considerations for the development of a closed-loop artificial pancreas system. J Diabetes Sci Technol (2011) 0.95
Multicenter closed-loop/hybrid meal bolus insulin delivery with type 1 diabetes. Diabetes Technol Ther (2014) 0.93
Automatic Detection of Stress States in Type 1 Diabetes Subjects in Ambulatory Conditions. Ind Eng Chem Res (2010) 0.93
Hypoglycemia begets hypoglycemia: the order effect in the ASPIRE in-clinic study. Diabetes Technol Ther (2014) 0.90
Continuous glucose monitors: current status and future developments. Curr Opin Endocrinol Diabetes Obes (2013) 0.90
Use of an intravascular fluorescent continuous glucose sensor in subjects with type 1 diabetes mellitus. J Diabetes Sci Technol (2012) 0.89
Improved A1C by switching to continuous subcutaneous insulin infusion from injection insulin therapy in type 2 diabetes: A retrospective claims analysis. Prim Care Diabetes (2010) 0.87
Continuous glucose monitoring health outcomes. Diabetes Technol Ther (2009) 0.87
The ASPIRE study: design and methods of an in-clinic crossover trial on the efficacy of automatic insulin pump suspension in exercise-induced hypoglycemia. J Diabetes Sci Technol (2011) 0.86
Continuous glucose monitoring during pregnancy. Diabetes Technol Ther (2009) 0.86
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY--CLINICAL PRACTICE GUIDELINES FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN--2015--EXECUTIVE SUMMARY. Endocr Pract (2015) 0.85
Resource utilization with insulin pump therapy for type 2 diabetes mellitus. Am J Manag Care (2010) 0.85
User acceptability and perceived benefits of new reports in CareLink Pro 3.0 Therapy Management Software for Diabetes. J Diabetes Sci Technol (2012) 0.85
Adaptive blood glucose control for intensive care applications. Comput Methods Programs Biomed (2012) 0.84
Retrospective analysis of diabetes care in California Medicaid patients with mental illness. J Gen Intern Med (2009) 0.83
CONTINUOUS GLUCOSE MONITORING: A CONSENSUS CONFERENCE OF THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY. Endocr Pract (2016) 0.80
Accuracy of the Sof-sensor glucose sensor with the iPro calibration algorithm. J Diabetes Sci Technol (2012) 0.79
Insulin pumps and their use in pregnancy. Diabetes Technol Ther (2010) 0.78
Dynamic insulin on board: incorporation of circadian insulin sensitivity variation. J Diabetes Sci Technol (2013) 0.78
A 16-week open-label, multicenter pilot study assessing insulin pump therapy in patients with type 2 diabetes suboptimally controlled with multiple daily injections. J Diabetes Sci Technol (2011) 0.78
An improved PID switching control strategy for type 1 diabetes. Conf Proc IEEE Eng Med Biol Soc (2006) 0.78
Robust parameter estimation in a model for glucose kinetics in type 1 diabetes subjects. Conf Proc IEEE Eng Med Biol Soc (2006) 0.78
Insulin pumps in pregnancy: using technology to achieve normoglycemia in women with diabetes. Curr Diab Rep (2012) 0.77
Automatic bolus and adaptive basal algorithm for the artificial pancreatic β-cell. Diabetes Technol Ther (2010) 0.77
An advisory protocol for rapid- and slow-acting insulin therapy based on a run-to-run methodology. Diabetes Technol Ther (2010) 0.77
In silico evaluation of an artificial pancreas combining exogenous ultrafast-acting technosphere insulin with zone model predictive control. J Diabetes Sci Technol (2013) 0.76
Physical activity and exercise. Diabetes Technol Ther (2014) 0.75
Recalculate total daily dose and confirm exactly how much insulin your patient is taking prior to changing mode of insulin delivery. Diabetes Technol Ther (2011) 0.75
Advances in exercise, physical activity, and diabetes mellitus. Diabetes Technol Ther (2013) 0.75